サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1663542

灌流画像診断の世界市場：アッセイの種類別・モダリティ別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)

Perfusion Radiology Market, By Assay Type, By Modality, By End Use, By Country, and By Region - Global Industry Analysis, Market Size, Market Share & Forecast from 2025-2032

出版日
ページ情報
英文 269 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=143.57円
灌流画像診断の世界市場：アッセイの種類別・モダリティ別・最終用途別・国別・地域別 - 産業分析、市場規模・シェア、将来予測 (2025年～2032年)
出版日: 2025年02月04日
発行: AnalystView Market Insights
ページ情報: 英文 269 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

レポートハイライト

灌流画像診断 (灌流放射線学) の市場規模は2024年に28億1,420万米ドルとなり、2025年から2032年にかけてCAGR 4.50%で拡大

灌流画像診断の市場力学

心血管および神経疾患の増加

ライフスタイルの変化や食習慣の乱れによって引き起こされる心血管疾患や神経疾患の増加により、灌流画像診断市場は拡大しています。脳卒中統計小委員会と米国心臓協会統計委員会が発表した統計によると、年間795,000人が心臓発作を起こしています。2017年には、この数字が公表されました。したがって、政府主導の取り組みや医療施設、その他の組織は、進行状況の監視や病気の治療に役立つ技術開発の知識を高めるための戦略を早急に考案しなければなりません。臓器の血流を測定する正確な画像診断法を用いることで、灌流画像診断は医師が異常を発見し、病気の経過を追跡し、治療がどの程度効果を上げているかを測定するのに役立ちます。灌流画像診断の採用は、複雑な神経学的問題や心血管系問題を治療するための正確で非侵襲的な診断技術に対するニーズの高まりによって促進されており、これが技術革新と市場拡大を後押ししています。

灌流画像診断市場：主な考察

弊社のリサーチアナリストの分析によると、世界市場は予測期間 (2025-2032年) に約4.50%のCAGRで毎年成長すると予測されています。

アッセイの種類別では、心血管画像診断が2024年に最大市場シェアを示すと予測されました。

最終用途別では、2024年には病院が主要セグメントでした。

地域別では、北米が2024年に収益を上げる主要市場です。

灌流画像診断市場：セグメンテーション分析

世界の灌流画像診断市場は、アッセイの種類、モダリティ、最終用途、地域に基づいてセグメント化されます。

アッセイの種類に基づき、市場は心血管画像診断、脳画像診断、換気画像診断に分別されます。2024年には、心血管疾患 (CVD) は世界的にますます一般的になっているため、市場は心血管画像診断カテゴリーが支配的でした。コンピュータ断層撮影 (CT) や磁気共鳴画像法 (MRI) のような画像技術の開発により、灌流画像診断は心臓疾患の特定や治療に、より正確で効果的なものとなっています。さらに、心血管画像診断技術に対するニーズは、医療費の上昇や早期診断・治療に対する意識の高まりによって高まっています。画像診断システムは、人工知能 (AI) の組み込みによってもたらされる診断精度のさらなる向上により、臨床診療において不可欠なものとなっています。

モダリティに基づき、市場は磁気共鳴画像法 (MRI) 、核医学、コンピュータ断層撮影法 (CT) に分けられます。2024年には、コンピュータ断層撮影 (CT) カテゴリーが、その広範な入手可能性、優れた診断精度、包括的な断面画像を提供する能力から、圧倒的な市場シェアを占めました。CTは脳卒中の管理や脳血流の評価に不可欠であり、低線量CTなどの開発がその利用を後押ししています。腫瘍学、神経学、心臓血管治療では、動脈スピンラベル (ASL) や動的造影 (DCE) 画像などの技術が広く利用されています。磁気共鳴画像法 (MRI) は、その優れた軟部組織コントラスト、非侵襲的機能、放射線を使用しない画像診断により、ますます普及しています。

灌流画像診断市場：地域別分析

2024年、北米は灌流画像診断の世界市場で圧倒的な地位を占めています。このリーダーシップは、同地域の医学研究への強力な投資、神経疾患や心血管疾患の高い有病率、確立された医療インフラによるものです。米国は、シーメンスやゼネラルエレクトリックのような市場参入企業が集中し、先進画像技術を積極的に導入していることから、この地域の成長を牽引しています。好意的な償還規制が、この地域における灌流画像診断市場の成長をさらに後押ししています。

しかし、予測期間を通じてCAGRが最も速いのは欧州地域です。ドイツ、フランス、英国は、その洗練された医療システム、最先端技術の普及、疾患の早期発見を奨励する政府プログラムにより、市場をリードしています。欧州では高齢化が進み、がんや脳卒中などの慢性疾患の有病率が上昇するにつれて、灌流画像診断技術はますます需要が高まっています。欧州連合 (EU) による医学研究促進への取り組みや国際医療パートナーシップは、灌流画像診断市場の拡大に拍車をかけています。

灌流画像診断市場：競合情勢

GENERAL ELECTRIC COMPANY、Siemens Healthineers AG、Sonic Healthcare、InHealth Group、RadNet, Inc.など、非常に競争の激しい灌流画像診断市場で、複数の競合がより大きなシェアを争っています。製薬会社、ソフトウェア・ソリューション・プロバイダー、医療用画像機器メーカーも重要な業界参加企業です。市場ポジションを向上させるため、これらの企業は研究開発、戦略的提携、M&A、新製品イントロダクション注力しています。製品ポートフォリオ、技術開拓、顧客サービス、価格政策、ブランドの評判は、市場競争力を決定する重要な要素です。医療プロバイダー独自の要件を満たし、患者ケアを向上させ、全体的な業務効率を高めるために、市場参入企業は包括的な灌流画像診断ソリューションを提供するために努力しています。例えば、2023年5月、スペインで開催されたEuropean Association of Cardiovascular Imaging (EACVI) の会議において、Ion Beam Applications S.A.からPET心筋灌流ベースの画像診断のための珍しい組み合わせソリューションであるAKURACYが発表され、この先進技術が紹介されました。EURONEXTのメンバーであるIBA社は、放射性医薬品製造ソリューションと粒子加速器技術開発のリーダーです。

目次

第1章 灌流画像診断市場の概要

  • 調査範囲
  • 市場推定期間

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 灌流画像診断の主な市場動向

  • 市場促進要因
  • 市場抑制要因
  • 市場機会
  • 市場の将来動向

第4章 灌流画像診断市場：産業分析

  • PEST分析
  • ポーターのファイブフォース分析
  • 市場成長の見通し：マッピング
  • 規制体制の分析

第5章 灌流画像診断市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 灌流画像診断の市場情勢

  • 灌流画像診断の市場シェア分析 (2024年)
  • 主要メーカー別の内訳データ
    • 既存企業の分析
    • 新興企業の分析

第7章 灌流画像診断市場：アッセイの種類別

  • 概要
    • セグメント別シェア分析：アッセイの種類別
    • 心血管画像診断
    • 脳画像診断
    • 換気画像診断

第8章 灌流画像診断市場：モダリティ別

  • 概要
    • セグメント別シェア分析：モダリティ別
    • 磁気共鳴画像 (MRI)
    • 核医学
    • コンピュータ断層撮影 (CT)

第9章 灌流画像診断市場：最終用途別

  • 概要
    • セグメント別シェア分析：最終用途別
    • 病院
    • 診療所
    • 診断検査室
    • その他

第10章 灌流画像診断市場：地域別

  • イントロダクション
  • 北米
    • 概要
    • 北米の主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 欧州の主要メーカー
    • ドイツ
    • フランス
    • イタリア
    • スペイン
    • 英国
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋 (APAC)
    • 概要
    • アジア太平洋の主要メーカー
    • インド
    • 中国
    • 韓国
    • 日本
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • ラテンアメリカの主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東・アフリカ
    • 概要
    • 中東・アフリカの主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析：灌流画像診断業界

  • 競合ダッシュボード
  • 企業プロファイル
    • GENERAL ELECTRIC COMPANY
    • Siemens Healthineers AG
    • Sonic Healthcare
    • InHealth Group
    • RadNet, Inc.
    • Spectrum Health
    • Alliance HealthCare Services
    • Hologic Inc.
    • Koninklijke Philips NV
    • RamSoft, Inc.
    • Others

第12章 AnalystViewの全方位的分析

目次
Product Code: ANV4697

REPORT HIGHLIGHT

Perfusion Radiology Market size was valued at US$ 2,814.2 Million in 2024, expanding at a CAGR of 4.50% from 2025 to 2032.

Perfusion radiology is the study of blood flow patterns in particular bodily parts, organs, or tissues. It entails giving contrast agents, which improve blood vessel visibility and make it easier to see blood flow in real-time. Perfusion radiology allows radiologists to evaluate tissue viability, spot regions of decreased or increased blood flow, and spot anomalies. This diagnostic method is non-invasive and essential for offering important information about how different organs work physiologically. The growing prevalence of chronic diseases, the need for precise diagnostic methods, and improvements in imaging technology are all contributing to the significant rise of the global perfusion radiology market. New software programs and imaging modalities that improve the precision and effectiveness of perfusion radiology procedures are being introduced to the market. Furthermore, the market is expanding due to rising patient and healthcare professional awareness of the advantages of perfusion radiology. Nonetheless, various obstacles, like the high cost of equipment and restricted accessibility in underdeveloped nations, can somewhat impede the perfusion radiology market expansion.

Perfusion Radiology Market- Market Dynamics

Increase in cardiovascular and neurological conditions

The market for perfusion radiology is growing as a result of an increase in cardiovascular and neurological conditions brought on by altered lifestyles and poor eating habits. According to statistics issued by the Stroke Statistics Subcommittee and the American Heart Association Statistics Committee, 795,000 persons have a heart attack annually. In 2017, these figures were made public. Government-funded initiatives, medical facilities, and other organizations must, therefore, immediately devise strategies to raise knowledge of the technological developments that aid in monitoring progress and curing the illness. By using accurate imaging methods to measure organ blood flow, perfusion radiology helps doctors spot anomalies, track the course of diseases, and gauge how well treatments are working. Perfusion radiology adoption is being fueled by the increasing need for precise and non-invasive diagnostic techniques to treat complicated neurological and cardiovascular problems, which is propelling innovation and market expansion.

Perfusion Radiology Market- Key Insights

As per the analysis shared by our research analyst, the global market is estimated to grow annually at a CAGR of around 4.50% over the forecast period (2025-2032)

Based on assay type segmentation, cardiovascular imaging was predicted to show maximum market share in the year 2024

Based on end-use segmentation, hospitals were the leading segment in 2024

On the basis of region, North America was the leading revenue generator in 2024

Perfusion Radiology Market- Segmentation Analysis:

The Global Perfusion Radiology Market is segmented on the basis of Assay Type, Modality, End Use, and Region.

On the basis of assay type, the market is segregated into Cardiovascular Imaging, Brain Imaging, and Ventilation Imaging. In 2024, the market was dominated by the cardiovascular imaging category because cardiovascular diseases (CVDs) are becoming more and more common worldwide. Perfusion radiology has become more accurate and effective in identifying and treating cardiac problems due to developments in imaging technologies like computed tomography (CT) and magnetic resonance imaging (MRI). Furthermore, the need for cardiovascular imaging technologies has been fueled by rising healthcare costs as well as increased awareness of early diagnosis and treatment. Imaging systems have become essential in clinical practice due to the further improvement in diagnostic precision brought about by the incorporation of artificial intelligence (AI).

Based on modality, the market is divided into Magnetic Resonance Imaging (MRI), Nuclear Medicine, and Computed Tomography (CT). In 2024, the computed tomography (CT) category held a dominant market share because of its extensive availability, excellent diagnostic precision, and capacity to provide comprehensive cross-sectional images. They are crucial for managing strokes and evaluating cerebral blood flow, and developments such as low-dose CT are encouraging their use. Oncology, neurology, and cardiovascular care all make extensive use of techniques like arterial spin labelling (ASL) and dynamic contrast-enhanced (DCE) imaging. Magnetic resonance imaging (MRI) is becoming more and more popular due to its superior soft-tissue contrast, non-invasive capabilities, and radiation-free imaging.

Perfusion Radiology Market- Geographical Insights

In 2024, North America held a dominant position in the global market for Perfusion Radiology. This leadership is ascribed to the region's strong investments in medical research, high prevalence of neurological and cardiovascular disorders, and well-established healthcare infrastructure. The United States primarily drives regional growth because of its large concentration of major market participants like Siemens and General Electric, as well as its robust adoption of advanced imaging technologies. Favourable reimbursement regulations further aid the growth of the perfusion radiology market in this area.

However, throughout the projected period, the Europe region is anticipated to see the fastest CAGR. Germany, France, and the UK are leading the way because of their sophisticated healthcare systems, widespread use of cutting-edge technologies, and government programs that encourage early disease detection. Perfusion radiology technologies are becoming more and more in demand as Europe's ageing population and the prevalence of chronic illnesses like cancer and stroke rise. The European Union's initiatives to promote medical research and international healthcare partnerships help fuel the perfusion radiology market expansion.

Perfusion Radiology Market- Competitive Landscape:

Several competitors are fighting for a larger share in the very competitive perfusion radiology market, such as GENERAL ELECTRIC COMPANY, Siemens Healthineers AG, Sonic Healthcare, InHealth Group, RadNet, Inc., and others. Pharmaceutical firms, software solution providers, and makers of medical imaging equipment are important industry participants. To improve their market position, these businesses concentrate on R&D, strategic alliances, mergers and acquisitions, and new product introductions. Product portfolio, technology developments, customer service, price policies, and brand reputation are important determinants of market competitiveness. In order to meet the unique requirements of healthcare providers, improve patient care, and increase overall operational efficiency, market participants work hard to deliver comprehensive perfusion radiology solutions. For instance, in May 2023, an unusual combination solution for PET myocardial perfusion-based imaging, AKURACY, was introduced by the Ion Beam Applications S.A. During the meeting of the European Association of Cardiovascular Imaging (EACVI) in Spain, this advanced technology was introduced. IBA, which is a member of EURONEXT, is a leader in the development of radiopharmaceutical production solutions and particle accelerator technologies.

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL PERFUSION RADIOLOGY MARKET KEY PLAYERS- DETAILED COMPETITIVE INSIGHTS

  • GENERAL ELECTRIC COMPANY
  • Siemens Healthineers AG
  • Sonic Healthcare
  • InHealth Group
  • RadNet, Inc.
  • Spectrum Health
  • Alliance HealthCare Services
  • Hologic Inc.
  • Koninklijke Philips N.V.
  • RamSoft, Inc.
  • Others

GLOBAL PERFUSION RADIOLOGY MARKET, BY ASSAY TYPE- MARKET ANALYSIS, 2019 - 2032

  • Cardiovascular Imaging
  • Brain Imaging
  • Ventilation Imaging

GLOBAL PERFUSION RADIOLOGY MARKET, BY MODALITY- MARKET ANALYSIS, 2019 - 2032

  • Magnetic Resonance Imaging (MRI)
  • Nuclear Medicine
  • Computed Tomography (CT)

GLOBAL PERFUSION RADIOLOGY MARKET, BY END USE- MARKET ANALYSIS, 2019 - 2032

  • Hospitals
  • Clinics
  • Diagnostic Laboratories
  • Others

GLOBAL PERFUSION RADIOLOGY MARKET, BY REGION- MARKET ANALYSIS, 2019 - 2032

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • The Netherlands
  • Sweden
  • Russia
  • Poland
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Australia
  • Indonesia
  • Thailand
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • UAE
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Perfusion Radiology Market Overview

  • 1.1. Study Scope
  • 1.2. Market Estimation Years

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Perfusion Radiology Market Snippet by Assay Type
    • 2.1.2. Perfusion Radiology Market Snippet by Modality
    • 2.1.3. Perfusion Radiology Market Snippet by End Use
    • 2.1.4. Perfusion Radiology Market Snippet by Country
    • 2.1.5. Perfusion Radiology Market Snippet by Region
  • 2.2. Competitive Insights

3. Perfusion Radiology Key Market Trends

  • 3.1. Perfusion Radiology Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Perfusion Radiology Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Perfusion Radiology Market Opportunities
  • 3.4. Perfusion Radiology Market Future Trends

4. Perfusion Radiology Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Perfusion Radiology Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Perfusion Radiology Market Landscape

  • 6.1. Perfusion Radiology Market Share Analysis, 2024
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Perfusion Radiology Market - By Assay Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Assay Type, 2024 & 2032 (%)
    • 7.1.2. Cardiovascular Imaging
    • 7.1.3. Brain Imaging
    • 7.1.4. Ventilation Imaging

8. Perfusion Radiology Market - By Modality

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Modality, 2024 & 2032 (%)
    • 8.1.2. Magnetic Resonance Imaging (MRI)
    • 8.1.3. Nuclear Medicine
    • 8.1.4. Computed Tomography (CT)

9. Perfusion Radiology Market - By End Use

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By End Use, 2024 & 2032 (%)
    • 9.1.2. Hospitals
    • 9.1.3. Clinics
    • 9.1.4. Diagnostic Laboratories
    • 9.1.5. Others

10. Perfusion Radiology Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2024 & 2032 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Perfusion Radiology Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Perfusion Radiology Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.8. France
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.8.3. France Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.8.4. France Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.8.5. France Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.9. Italy
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.9.3. Italy Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.9.4. Italy Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.9.5. Italy Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.10. Spain
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.10.3. United Kingdom Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.10.4. United Kingdom Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.10.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.11. United Kingdom
      • 10.3.11.1. Overview
      • 10.3.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.11.3. United Kingdom Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.11.4. United Kingdom Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.11.5. United Kingdom Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.12. Russia
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.12.2. Russia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.12.3. Russia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.12.4. Russia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.13. Netherlands
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.13.2. Netherlands Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.13.3. Netherlands Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.13.4. Netherlands Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.14. Sweden
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.14.2. Sweden Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.14.3. Sweden Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.14.4. Sweden Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.15. Poland
      • 10.3.15.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.15.2. Poland Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.15.3. Poland Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.15.4. Poland Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.3.16. Rest of Europe
      • 10.3.16.1. Overview
      • 10.3.16.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.3.16.3. Rest of the Europe Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.3.16.4. Rest of the Europe Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.3.16.5. Rest of the Europe Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Perfusion Radiology Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.9. South Korea
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.9.3. South Korea Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.9.4. South Korea Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.9.5. South Korea Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.10. Japan
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.10.3. Japan Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.10.4. Japan Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.10.5. Japan Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Perfusion Radiology Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Perfusion Radiology Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2019 - 2032 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2019 - 2032, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Assay Type, 2019 - 2032 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Modality, 2019 - 2032 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By End Use, 2019 - 2032 (US$ Million)

11. Key Vendor Analysis- Perfusion Radiology Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. GENERAL ELECTRIC COMPANY
    • 11.2.2. Siemens Healthineers AG
    • 11.2.3. Sonic Healthcare
    • 11.2.4. InHealth Group
    • 11.2.5. RadNet, Inc.
    • 11.2.6. Spectrum Health
    • 11.2.7. Alliance HealthCare Services
    • 11.2.8. Hologic Inc.
    • 11.2.9. Koninklijke Philips N.V.
    • 11.2.10. RamSoft, Inc.
    • 11.2.11. Others

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us